PSYCH OpenIR  > 健康与遗传心理学研究室
Culturally Adapted CBTI for Chinese Insomnia Patients: a One-Arm Pilot Trial
Birling, Yoann1; Wang, Jian1; Li, Guixia1; Wu, Enlai2; Yu, Zhidan2; Feng, Yunshu1; Wu, Yuting2
2018-06-01
发表期刊INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
ISSN1070-5503
卷号25期号:3页码:331-340
摘要Insomnia is a common mental disorder with severe consequences. Cognitive-behavioral therapy for insomnia (CBTI) has been proved effective against insomnia, but most of the research is limited to Western countries. This trial objective is to develop a Chinese culture-adapted CBTI program and assess its efficacy. An 8-week culturally adapted CBTI program was developed that included mixed group and individual session and culturally adapted relaxation and cognitive restructuring treatment components. A one-arm clinical trial was conducted at a public hospital between March 2016 and January 2017. Seventy-two Chinese adults (15 males, 57 females; mean age, 50 years) with insomnia disorder underwent the culturally adapted CBTI program. Sleep diaries and self-report scales, as well as polysomnography (PSG, for a subgroup only), were used to assess qualitative and quantitative measures of sleep, mental health status, and quality of life at baseline, post-treatment, and 4-month follow-up. Pre-post analyses showed significant changes in sleep diary sleep onset latency (SOL), wake after sleep onset (WASO), and total sleep time of respectively - 37.03 min (CI, - 48.90 to - 25.16), - 28.16 min (CI, - 40.22 to - 16.10), and + 27.49 min (CI, 10.51 to 44.47). Self-reported sleep quality, mental health, and quality of life improved compared to baseline. The self-reported outcomes were mainly stable at follow-up. PSG outcomes globally failed to show improvement. The design of a CBTI program adapted to Chinese population was achieved. Culturally adapted CBTI showed promising results. More rigorously designed studies are needed to ensure efficacy.
关键词Insomnia Clinical trial Treatment Cognitive-behavioral therapy Cultural adaptation
DOI10.1007/s12529-017-9710-z
语种英语
项目资助者project "clinical pathways and comprehensive intervention model of insomnia pharmacological and psychological treatment" - Beijing Municipal Commission of Science and Technology ; project "insomnia clinical research bases on the courage determining judgment and response" - Guang'an Men Hospital
资助项目project "clinical pathways and comprehensive intervention model of insomnia pharmacological and psychological treatment" - Beijing Municipal Commission of Science and Technology[Z121107001012034] ; project "insomnia clinical research bases on the courage determining judgment and response" - Guang'an Men Hospital[2016S358]
WOS研究方向Psychology
WOS类目Psychology, Clinical
WOS记录号WOS:000432362600007
出版者SPRINGER
关键词[WOS]COGNITIVE-BEHAVIORAL THERAPY ; RANDOMIZED CONTROLLED-TRIAL ; SLEEP QUALITY INDEX ; SEVERITY INDEX ; PSYCHOMETRIC PROPERTIES ; PERSISTENT INSOMNIA ; GENERAL-POPULATION ; CLINICAL-TRIALS ; HEALTH ; METAANALYSIS
引用统计
文献类型期刊论文
条目标识符http://ir.psych.ac.cn/handle/311026/26488
专题健康与遗传心理学研究室
通讯作者Wang, Jian
作者单位1.Guangan Men Hosp, Beijing 100053, Peoples R China
2.Chinese Acad Sci, Inst Psychol, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714
Birling, Yoann,Wang, Jian,Li, Guixia,et al. Culturally Adapted CBTI for Chinese Insomnia Patients: a One-Arm Pilot Trial[J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE,2018,25(3):331-340.
APA Birling, Yoann.,Wang, Jian.,Li, Guixia.,Wu, Enlai.,Yu, Zhidan.,...&Wu, Yuting.(2018).Culturally Adapted CBTI for Chinese Insomnia Patients: a One-Arm Pilot Trial.INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE,25(3),331-340.
MLA Birling, Yoann,et al."Culturally Adapted CBTI for Chinese Insomnia Patients: a One-Arm Pilot Trial".INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 25.3(2018):331-340.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Birling, Yoann]的文章
[Wang, Jian]的文章
[Li, Guixia]的文章
百度学术
百度学术中相似的文章
[Birling, Yoann]的文章
[Wang, Jian]的文章
[Li, Guixia]的文章
必应学术
必应学术中相似的文章
[Birling, Yoann]的文章
[Wang, Jian]的文章
[Li, Guixia]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。